ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1941

Microenvironmental and Systematic Evaluation of the Immunome in Osteoarthritis

Bhairav Paleja1, Ying Ying Leung2, Pavanish Kumar1, Suzan Saidin1, Ahmad Lajam2, Liyun Lai1 and Salvatore Albani1, 1SingHealth Translational Immunology and Inflammation Centre (STIIC), Duke-NUS Medical School, Singapore, Singapore, 2Singapore General Hospital, Singapore, Singapore

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: CyTOF, T cells and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Biology and Pathology of Bone and Joint Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Osteoarthritis is the most common joint disease and involves whole joint, including degeneration of articular cartilage and surrounding tissues. Although widely prevalent, the exact mechanisms involved in pathogenesis of OA are not well understood. Increasing body of data suggest role of low-grade, subclinical, in pathogenesis of OA. However the role of immune cell subsets in OA is poorly investigated. In present study we have applied a combination of single cell mass cytometry for analysis of the peripheral immunome and next generation RNA-sequencing on cell pellet from knee joint fluid to characterise immune cells and pathways.

Methods:

Patients samples were taken from a randomized controlled trial on treatment of symptomatic knee OA using colchicine for 16 weeks (1)(2). Patients were grouped as having ≥30% improvement in WOMAC (improvement group) and improvement of WOMAC not reaching 30%(Worsening group) at study end regardless of treatment arms. For RNA sequencing analysis 16 paired patient samples, from baseline and study end, were used. For mass cytometry analysis, 37 marker panel was designed to aid in identification of major peripheral blood mononuclear cell (PBMCs) subsets. Unsupervised clustering of mass cytometry data was performed using in-house developed analysis software MARVIS. This software combines dimension reduction and clustering steps to identify all possible cellular subsets from high dimension data. Further, custom R scripts helped in identifying nodes that were differentially expressed between the study groups and also phenotype of these nodes.

Results:

Differential gene expression analysis comparing baseline vs week 16 from worsening group revealed changes in 696 genes and in improvement group 89 genes were identified. Estimation of cell type abundances, using Cibersort algorithm, showed increased frequency of M2 macrophages, follicular helper T cells and activated NK cells in worsening group and increased memory CD4 T cells in improvement group. Mass cytometry analysis of PBMCs showed increase in inflammatory Tbet+ ILC subsets in worsening group (n=6) and an increase in Th2 like GATA3+ CD4 T cells in improvement group (n=6) at baseline.

Conclusion:

Our systematic multi dimensional approach reveals differences in the alteration of immune cells in knee OA patients with/ without symptoms improvement, both at synovial fluid level and systemic blood level. Further analysis may provide insights into mechanistic pathways involved in pathogenesis of OA, the interaction between tissue and systemic circulation and for advent of novel OA therapies.


Disclosure: B. Paleja, None; Y. Y. Leung, None; P. Kumar, None; S. Saidin, None; A. Lajam, None; L. Lai, None; S. Albani, None.

To cite this abstract in AMA style:

Paleja B, Leung YY, Kumar P, Saidin S, Lajam A, Lai L, Albani S. Microenvironmental and Systematic Evaluation of the Immunome in Osteoarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/microenvironmental-and-systematic-evaluation-of-the-immunome-in-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microenvironmental-and-systematic-evaluation-of-the-immunome-in-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology